Back

Asymmetric risk score architecture in atrial fibrillation: renal impairment inflates bleeding but not thrombotic risk estimation

28 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: prevention and modifiable risk factors Prevention ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Magdalini Petridou

Aristotle University of Thessaloniki, Thessaloniki (Greece)

3 More presentations in this session

Presentation thumbnail
Effectiveness of bivalent RSV prefusion F protein-based vaccine in individuals with and without atrial fibrillation: a prespecified analysis of the DAN-RSV trial
Doctor C. Espersen (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
Association between systolic blood pressure time in target range and incident atrial fibrillation: a prospective cohort study in the UK Biobank
Professor H. Bao (Nanchang, CN)
Abstract Slides Video
Presentation thumbnail
Non-linear associations between systolic blood pressure and clinical outcomes in atrial fibrillation and net clinical benefit of oral anticoagulants: a dose-response meta-analysis
Doctor E. Shahmohamadi (Adelaide, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: prevention and modifiable risk factors

The Event

Event poster

ESC Congress 2026

28 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Head-to-head comparison of CHADS₂, CHA₂DS₂-VASc, CHA₂DS₂-VA, HAS-BLED, and HELT-E₂S₂ scores in edoxaban treated atrial fibrillation patients: a 2-year analysis from the ETNA-AF Global program
28 August 2026
thumbnail
Congress Presentation
Renal dysfunction drives recurrence and modifies safety after atrial fibrillation ablation: a contemporary retrospective analysis of CKD stage and energy source interaction
29 August 2026
thumbnail
Congress Presentation
CKD severity and high bleeding risk in patients undergoing PCI: stage-specific validation of modified ARC-HBR criteria
31 August 2026
thumbnail
Congress Presentation
Vascular disease and renal impairment mediate the higher thromboembolic risk in atrial fibrillation patients with heart failure with reduced ejection fraction
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources